Repligen Corp

자세한 내용은 Repligen Corp 회사

Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems. Its focus areas are Filtration and Fluid Management, Chromatography, Process Analytics and Proteins. Its filtration products are used in process development and process scale (clinical and commercial) production. Its XCell ATF systems are used in upstream perfusion (continuous) and N-1 (intensified fed-batch or hybrid perfusion) cell culture processing. Its chromatography franchise includes several products used in downstream purification, development, manufacturing and quality control of biological drugs. Its process analytics products complement and support its filtration, chromatography and protein franchises. Its TangenX product portfolio includes flat sheet (FS) tangential flow filtration (TFF) cassettes used primarily in downstream and ultrafiltration processes. Its desktop portfolio includes MAVERICK and MAVEN, REBEL, and ZipChip.

회사 정보

종목 코드 RGEN

회사 이름Repligen Corp

상장일Apr 29, 1986

설립일1981

CEOMr. Olivier Loeillot

직원 수1778

유형Ordinary Share

회계 연도 종료Apr 29

주소Building 1, Suite 100

도시WALTHAM

증권 거래소NASDAQ Global Select Consolidated

국가United States of America

우편 번호02453

전화17814499560

웹사이트https://www.repligen.com/

종목 코드 RGEN

상장일Apr 29, 1986

설립일1981

회사 임원

이름

이름/직위

직위

주식 보유

변동

Ms. Karen A. Dawes

Lead Independent Director

91.29K

+1.08%

Mr. Glenn P. Muir

Independent Director

32.55K

+3.08%

Mr. Olivier Loeillot

President, Chief Executive Officer, Director

16.82K

-47.79%

Mr. Ralf Kuriyel

Senior Vice President - Research and Development

12.56K

+147.18%

Mr. Nicolas M. Barthelemy

Independent Director

4.94K

+24.53%

Mr. Rohin Mhatre, Ph.D.

Independent Director

3.32K

+41.49%

Dr. Konstantin Konstantinov, Ph.D.

Independent Director

--

Mr. Jason K. Garland

Chief Financial Officer

--

Mr. Tony John Hunt

Executive Chairman of the Board

--

Dr. Martin D. Madaus, Ph.D.

Independent Director

--

이름

이름/직위

직위

주식 보유

변동

Ms. Karen A. Dawes

Lead Independent Director

91.29K

+1.08%

Mr. Glenn P. Muir

Independent Director

32.55K

+3.08%

Mr. Olivier Loeillot

President, Chief Executive Officer, Director

16.82K

-47.79%

Mr. Ralf Kuriyel

Senior Vice President - Research and Development

12.56K

+147.18%

Mr. Nicolas M. Barthelemy

Independent Director

4.94K

+24.53%

Mr. Rohin Mhatre, Ph.D.

Independent Director

3.32K

+41.49%

수익 분석

통화: USD마지막 업데이트: Sun, Jul 6

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021

FY2020

FY2019

FY2018

데이터 없음

지역별USD

이름

수익

비율

North America

84.59M

50.00%

Europe

59.21M

35.00%

APAC/Other

25.38M

15.00%

사업별

지역별

데이터 없음

주식 보유 통계

마지막 업데이트: Sun, May 18

주주

주주 유형

주주

비율

T. Rowe Price Associates, Inc.

13.38%

The Vanguard Group, Inc.

9.02%

BlackRock Institutional Trust Company, N.A.

8.70%

Roy T. Eddleman UEO

5.89%

State Street Global Advisors (US)

3.01%

Other

60.00%

주주

비율

T. Rowe Price Associates, Inc.

13.38%

The Vanguard Group, Inc.

9.02%

BlackRock Institutional Trust Company, N.A.

8.70%

Roy T. Eddleman UEO

5.89%

State Street Global Advisors (US)

3.01%

Other

60.00%

주주 유형

주주

비율

Investment Advisor

53.24%

Investment Advisor/Hedge Fund

36.52%

Hedge Fund

9.08%

Individual Investor

6.40%

Pension Fund

2.44%

Research Firm

1.88%

Bank and Trust

0.70%

Family Office

0.52%

Family Office

0.50%

기관 주식 보유

마지막 업데이트: Tue, Jul 1

보고 기간

기관 수

보유 주식

비율

변동

2025Q2

1017

62.55M

111.32%

-2.87M

2025Q1

1054

62.91M

111.98%

-2.72M

2024Q4

1054

61.13M

109.11%

-3.76M

2024Q3

1046

60.75M

108.48%

-6.10M

2024Q2

1039

61.28M

109.67%

-2.73M

2024Q1

1036

60.56M

108.45%

-5.41M

2023Q4

1062

62.13M

111.29%

-2.30M

2023Q3

1063

61.47M

110.27%

+2.91M

2023Q2

1050

59.01M

105.99%

+1.34M

2023Q1

1061

58.23M

104.67%

+1.01M

주주 활동

이름

보유 주식

비율

변동

Chg %

날짜

T. Rowe Price Associates, Inc.

7.52M

13.38%

+427.74K

+6.03%

Mar 31, 2025

The Vanguard Group, Inc.

5.07M

9.02%

-21.20K

-0.42%

Mar 31, 2025

BlackRock Institutional Trust Company, N.A.

4.89M

8.7%

+13.96K

+0.29%

Mar 31, 2025

Roy T. Eddleman UEO

3.31M

5.89%

-67.50K

-2.00%

Dec 31, 2024

State Street Global Advisors (US)

1.69M

3.01%

-2.27K

-0.13%

Mar 31, 2025

Invesco Advisers, Inc.

1.60M

2.84%

+768.85K

+93.02%

Mar 31, 2025

Champlain Investment Partners, LLC

1.46M

2.61%

-79.53K

-5.15%

Mar 31, 2025

Citadel Advisors LLC

1.33M

2.37%

+150.23K

+12.74%

Mar 31, 2025

Sands Capital Management, LLC

1.29M

2.3%

-70.06K

-5.14%

Mar 31, 2025

BlackRock Financial Management, Inc.

1.22M

2.17%

-37.63K

-2.99%

Mar 31, 2025

118.100USD

Repligen Corp

118.100

개요

회사

금융